Gerresheimer has signed up to support development of Portal Instruments’ needle-free drug delivery platform, taking a stake in its new partner and agreeing to throw its weight behind a technology that has attracted the attention of Takeda.
Source: Gerresheimer invests in Portal’s needle-free drug delivery | Fierce Pharma